COLOMATE: Colorectal Cancer Liquid Biopsy Screening for Molecularly Assigned Therapy - Clinical Trial

What is the Purpose of this Study?

We are doing this study to use a blood test to find out what mutations (genetic changes) your cancer cells might have.

We would like to use this information to see if there is a research study available that may be a good fit for you by targeting these mutations.

What is the Condition Being Studied?

Colorectal Cancer

Who Can Participate in the Study?

Adults, 18+ who:
- Have a history of adenocarcinoma of the colon or rectum that is metastatic and/ or unresectable
- Are willing to provide blood sample
- Have not had a solid organ transplantation

Age Group
Adults

What is Involved?

If you choose to join this study you will:
-Give a blood sample to see if your tumor cells have any genetic changes (mutations)
-Get the results of your blood test and a list of any available research studies that match you within 2-3 weeks
-Have a follow-up phone call about 30 days after starting the study

Study Details

Full Title
COLOMATE: COlorectal Cancer Liquid BiOpsy Screening Protocol for Molecularly Assigned ThErapy
Principal Investigator
Medical Oncologist
Protocol Number
IRB: PRO00104245
NCT: NCT03765736
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698